Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 28-Feb 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4688933015 | Niraparib tosylate | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4688934014 | Niraparib tosylate (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Niraparib tosylate | Is a | Piperazine derivative | true | Inferred relationship | Some | ||
| Niraparib tosylate | Is a | Antineoplastic agent (substance) | true | Inferred relationship | Some | ||
| Niraparib tosylate | Is a | Enzyme inhibitor | false | Inferred relationship | Some | ||
| Niraparib tosylate | Is a | Nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase inhibitor | true | Inferred relationship | Some | ||
| Niraparib tosylate | Has disposition (attribute) | Nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase inhibitor (disposition) | true | Inferred relationship | Some | ||
| Niraparib tosylate | Is modification of (attribute) | Niraparib (substance) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Niraparib (as niraparib tosylate) 100 mg oral capsule | Has precise active ingredient | True | Niraparib tosylate | Inferred relationship | Some | 1 |
| Niraparib tosylate monohydrate | Is modification of (attribute) | True | Niraparib tosylate | Inferred relationship | Some | |
| Niraparib tosylate anhydrous | Is modification of (attribute) | True | Niraparib tosylate | Inferred relationship | Some |
Reference Sets
FHIR